CIBC World Market’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86K | Buy |
25,065
+1,500
| +6% | +$5.15K | ﹤0.01% | 1243 |
|
|
2025
Q1 | $52.6K | Buy |
23,565
+6,700
| +40% | +$14.9K | ﹤0.01% | 1241 |
|
|
2024
Q4 | $49K | Sell |
16,865
-800
| -5% | -$2.32K | ﹤0.01% | 1249 |
|
|
2024
Q3 | $46K | Sell |
17,665
-500
| -3% | -$1.3K | ﹤0.01% | 1194 |
|
|
2024
Q2 | $54K | Buy |
18,165
+2,940
| +19% | +$8.74K | ﹤0.01% | 1161 |
|
|
2024
Q1 | $69K | Buy |
15,225
+850
| +6% | +$3.85K | ﹤0.01% | 1183 |
|
|
2023
Q4 | $82K | Sell |
14,375
-12,430
| -46% | -$70.9K | ﹤0.01% | 1123 |
|
|
2023
Q3 | $123K | Sell |
26,805
-10,300
| -28% | -$47.3K | ﹤0.01% | 1095 |
|
|
2023
Q2 | $240K | Sell |
37,105
-1,900
| -5% | -$12.3K | ﹤0.01% | 1016 |
|
|
2023
Q1 | $294K | Buy |
39,005
+5,330
| +16% | +$40.2K | ﹤0.01% | 980 |
|
|
2022
Q4 | $341K | Buy |
33,675
+1,500
| +5% | +$15.2K | ﹤0.01% | 915 |
|
|
2022
Q3 | $318K | Buy |
32,175
+5,700
| +22% | +$56.3K | ﹤0.01% | 912 |
|
|
2022
Q2 | $282K | Sell |
26,475
-2,425
| -8% | -$25.8K | ﹤0.01% | 968 |
|
|
2022
Q1 | $282K | Sell |
28,900
-11,053
| -28% | -$108K | ﹤0.01% | 1059 |
|
|
2021
Q4 | $571K | Sell |
39,953
-37,287
| -48% | -$533K | ﹤0.01% | 868 |
|
|
2021
Q3 | $1.55M | Buy |
77,240
+9,097
| +13% | +$182K | 0.01% | 616 |
|
|
2021
Q2 | $1.5M | Buy |
68,143
+10,918
| +19% | +$240K | ﹤0.01% | 634 |
|
|
2021
Q1 | $1.94M | Buy |
+57,225
| New | +$1.94M | 0.01% | 538 |
|